Digest Network Come funziona
Network
/
Società
Al
Non verificato

Alterome Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

6 comunicati stampa

Guarda tutti i comunicati
10/04/2025
Mercato del lavoro
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Alterome Therapeutics Announces New Chief Executive Officer and Chair of the Board of Directors
Fonte
Alterome Therapeutics, Inc.
Emittente
Business Wire
1.00
0
10/03/2025
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Alterome Doses First Patient in Phase 1 Study of ALTA3263, a Novel Pan-KRAS Dual ON/OFF Inhibitor, in Advanced Solid Tumors
Fonte
Alterome Therapeutics, Inc.
Emittente
Business Wire
1.00
0
25/02/2025
Oncologia
Salute
Medicina - Varie
Scienza
Biotecnologia
Eventi
Alterome Therapeutics to Participate in Upcoming Investor Conferences
Fonte
Alterome Therapeutics, Inc.
Emittente
Business Wire
1.00
0
30/10/2024
Industria
Scienza
Biotecnologia
Farmaceutica
Oncologia
Sanità
Salute
Medicina - Varie
Alterome Therapeutics Announces First Patient Dosed in Phase 1 Study of ALTA2618 in AKT1 E17K-mutant solid tumors (AKTive-001)
Fonte
Alterome Therapeutics, Inc.
Emittente
Business Wire
1.00
0
25/10/2024
Eventi
Industria
Scienza
Biotecnologia
Sanità
Salute
Farmaceutica
Oncologia
Alterome Therapeutics to Present Preclinical Data for its KRAS Selective Inhibitor ALTA3263 at the 2024 ENA Symposium
Fonte
Alterome Therapeutics, Inc.
Emittente
Business Wire
1.00
0
17/10/2024
Eventi
Mercato del lavoro
Associazioni/Professionisti
Oncologia
Salute
Farmaceutica
Biotecnologia
Eric Murphy, Ph.D., Co-Founder and CEO of Alterome, Named to Goldman Sachs Top 100 Most Exceptional Entrepreneurs at 2024 Builders and Innovators Summit
Fonte
Alterome Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0